Objectives: 1.To measure plasma NT- proBNP levels, shape and function of left ventricle of diabetic type 2 patients, and (2) To explore the correlation between plasma NT-proBNP levels and the shape and function of the left ventricle, and heart failure according to Framingham, NYHA, and ACC/AHA criteria. Materials and Methods: Cross-sectional and descriptive study on 104 diabetic type 2 patients through the measurements of plasma NT-proBNP levels, ECG and Doppler echocardiography. Results: Average plasma NT-proBNP level: 142.17 ± 186.95 pg/ml. The results highlighted that: (1) Plasma NT-proBNP level significantly increases with age, the detection time, the severity of clinical heart failure, left ventricle hypertrophy, and diastolic-systolic dysfunction of left ventricle (p <0.05), and (2) Plasma NT-proBNP level significantly correlates with heart failure based on Framingham criteria (r = 0.66; p < 0.001), functional heart failure based on NYHA classification (r = 0.676; p < 0.001), the stage of heart failure based on the ACC/AHA guidelines (r = 0.709; p < 0.001), left ventricle hypertrophy based on Sokolow-Lyon (r = 0.346; QTc (r = 0.471; p < 0.001), LVMI (r = 0,701; p < 0,001), diastolic dysfunction grades (r = 0.604; p < 0.001), DTE (r = 0.437; p < 0.001), IVRT (r = 0.29; p = 0.003), EF (r = - 0.414; p < 0.001), and systolic dysfunction grades (r = 0.502; p < 0.001). Conclusion : At the cut-point of 125 pg/ml, plasma NT-proBNP level has the prognostic value of left ventricle hypertrophy, and diastolic-systolic dysfunction of left ventricle in diabetic type 2 patients.
Read full abstract